ETGLX: Eventide Gilead Fund - MutualFunds.com
Continue to site >
Trending ETFs

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Eventide Gilead N

ETGLX - Snapshot

Vitals

  • YTD Return 12.7%
  • 3 Yr Annualized Return 26.6%
  • 5 Yr Annualized Return 26.8%
  • Net Assets $5.21 B
  • Holdings in Top 10 31.8%

52 WEEK LOW AND HIGH

$70.33
$48.89
$71.18

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.38%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 35.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $1,000
  • IRA $1,000

Fund Classification


Compare ETGLX to Popular U.S. Mid-Cap Growth Equity Funds and ETFs

Overview

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

$141.54

+0.96%

$114.53 B

-

$0.00

13.39%

0.19%

$186.62

+0.97%

$114.53 B

1.21%

$2.24

13.31%

0.06%

$89.65

+0.95%

$42.62 B

0.90%

$0.80

7.39%

0.04%

$92.36

+0.62%

$40.44 B

-

$0.00

12.25%

0.75%

$126.00

+0.82%

$39.01 B

-

$0.00

11.43%

0.73%

ETGLX - Profile

Distributions

  • YTD Total Return 12.7%
  • 3 Yr Annualized Total Return 26.6%
  • 5 Yr Annualized Total Return 26.8%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.63%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Eventide Gilead Fund
  • Fund Family Name
    Eventide Funds
  • Inception Date
    Jul 08, 2008
  • Shares Outstanding
    N/A
  • Share Class
    N
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Finny Kuruvilla

ETGLX - Performance

Return Ranking - Trailing

Period ETGLX Return Category Return Low Category Return High Rank in Category (%)
YTD 12.7% -81.7% 59.1% 30.39%
1 Yr 49.4% 20.3% 114.1% 25.17%
3 Yr 26.6%* 3.2% 51.5% 13.10%
5 Yr 26.8%* 10.7% 48.5% 7.22%
10 Yr 18.6%* 8.5% 20.6% 1.98%

* Annualized

Return Ranking - Calendar

Period ETGLX Return Category Return Low Category Return High Rank in Category (%)
2020 53.9% -69.7% 2474.5% 10.40%
2019 29.6% -50.2% 44.0% 29.34%
2018 -7.5% -70.5% 9.2% 16.23%
2017 32.9% -21.1% 84.9% 4.98%
2016 0.9% -61.7% 20.7% 54.16%

Total Return Ranking - Trailing

Period ETGLX Return Category Return Low Category Return High Rank in Category (%)
YTD 12.7% -81.6% 59.1% 30.71%
1 Yr 49.4% 14.3% 114.1% 23.51%
3 Yr 26.6%* -4.3% 51.5% 11.71%
5 Yr 26.8%* 10.7% 48.5% 6.74%
10 Yr 18.6%* 8.5% 20.6% 1.78%

* Annualized

Total Return Ranking - Calendar

Period ETGLX Return Category Return Low Category Return High Rank in Category (%)
2020 53.9% -69.7% 2474.5% 10.40%
2019 29.6% -50.2% 44.0% 29.34%
2018 -7.5% -51.7% 12.2% 37.13%
2017 32.9% -7.0% 84.9% 7.77%
2016 0.9% -61.7% 20.7% 80.60%

NAV & Total Return History


ETGLX - Holdings

Concentration Analysis

ETGLX Category Low Category High ETGLX % Rank
Net Assets 5.21 B 1.09 M 115 B 22.53%
Number of Holdings 77 19 3511 51.85%
Net Assets in Top 10 1.46 B 2.46 K 12.6 B 19.23%
Weighting of Top 10 31.84% 3.8% 95.0% 28.59%

Top 10 Holdings

  1. Us Bank Mmda - Usbgfs5 5.98%
  2. Us Bank Mmda - Usbgfs5 5.98%
  3. Us Bank Mmda - Usbgfs5 5.98%
  4. Us Bank Mmda - Usbgfs5 5.98%
  5. Us Bank Mmda - Usbgfs5 5.98%
  6. Us Bank Mmda - Usbgfs5 5.98%
  7. Us Bank Mmda - Usbgfs5 5.98%
  8. Us Bank Mmda - Usbgfs5 5.98%
  9. Us Bank Mmda - Usbgfs5 5.98%
  10. Us Bank Mmda - Usbgfs5 5.98%

Asset Allocation

Weighting Return Low Return High ETGLX % Rank
Stocks
93.59% 17.87% 100.60% 93.39%
Cash
4.11% -0.60% 23.11% 10.15%
Bonds
1.26% 0.00% 14.28% 1.08%
Other
1.04% -0.96% 56.87% 6.92%
Preferred Stocks
0.00% 0.00% 1.36% 44.00%
Convertible Bonds
0.00% 0.00% 0.30% 39.38%

Stock Sector Breakdown

Weighting Return Low Return High ETGLX % Rank
Technology
36.72% 0.00% 61.26% 13.54%
Healthcare
18.34% 0.00% 40.53% 61.23%
Industrials
17.10% 0.00% 37.55% 23.69%
Consumer Cyclical
12.66% 0.00% 61.62% 66.46%
Communication Services
6.42% 0.00% 31.17% 33.54%
Utilities
4.66% 0.00% 9.13% 1.23%
Consumer Defense
2.33% 0.00% 14.47% 48.62%
Real Estate
1.77% 0.00% 11.85% 47.54%
Financial Services
0.00% 0.00% 36.63% 97.54%
Energy
0.00% 0.00% 72.54% 64.31%
Basic Materials
0.00% 0.00% 22.11% 83.54%

Stock Geographic Breakdown

Weighting Return Low Return High ETGLX % Rank
US
83.39% 17.86% 100.00% 93.23%
Non US
10.20% 0.00% 56.41% 8.92%

Bond Sector Breakdown

Weighting Return Low Return High ETGLX % Rank
Cash & Equivalents
76.91% 0.00% 100.00% 92.19%
Corporate
23.09% 0.00% 100.00% 6.28%
Derivative
0.00% 0.00% 5.67% 39.05%
Securitized
0.00% 0.00% 32.46% 38.54%
Municipal
0.00% 0.00% 1.26% 38.54%
Government
0.00% 0.00% 26.26% 39.56%

Bond Geographic Breakdown

Weighting Return Low Return High ETGLX % Rank
US
1.26% 0.00% 10.31% 0.77%
Non US
0.00% 0.00% 3.97% 38.62%

ETGLX - Expenses

Operational Fees

ETGLX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.38% 0.01% 2.77% 20.99%
Management Fee 1.00% 0.00% 1.50% 93.34%
12b-1 Fee 0.20% 0.00% 1.00% 28.07%
Administrative Fee 0.10% 0.01% 0.40% 49.57%

Sales Fees

ETGLX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.50% N/A

Trading Fees

ETGLX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.20% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

ETGLX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 35.00% 0.00% 457.00% 34.50%

ETGLX - Distributions

Dividend Yield Analysis

ETGLX Category Low Category High ETGLX % Rank
Dividend Yield 0.00% 0.00% 0.19% 40.52%

Dividend Distribution Analysis

ETGLX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

ETGLX Category Low Category High ETGLX % Rank
Net Income Ratio -0.63% -69.00% 1.47% 66.27%

Capital Gain Distribution Analysis

ETGLX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

ETGLX - Fund Manager Analysis

Managers

Finny Kuruvilla


Start Date

Tenure

Tenure Rank

Jul 08, 2008

12.99

13.0%

Finny Kuruvilla, M.D., Ph.D., has been primarily responsible for the day-to-day management of the Gilead Fund and Healthcare & Life Sciences Fund since inception. Dr. Kuruvilla has been the Managing Partner of the Adviser since its inception in 2008. Dr. Kuruvilla possesses a diverse background in quantitative methods, with applications focused on innovations in science, engineering, and medicine. He holds an MD from Harvard Medical School, a PhD in Chemistry and Chemical Biology from Harvard University, a master’s degree in Electrical Engineering and Computer Science from MIT, and a bachelor’s degree from Caltech in Chemistry. From 2005-2008, Dr. Kuruvilla was a clinical fellow at the Brigham and Women's Hospital and a postdoctoral scientist at MIT. As an avid proponent of values-based investing, Dr. Kuruvilla has established rigorous standards in seeking out the most ethical companies at the outset of the stock selection process. In addition to his role with the Adviser, Dr. Kuruvilla is a founder, financial sponsor, and Board Director of Sattler College, a four-year college in Boston, Massachusetts, opened in 2018. Dr. Kuruvilla also contributes to the college in a limited faculty role. From 2008-2016, Dr. Kuruvilla provided research services as an employee of Clarus Ventures, a healthcare and life sciences venture capital firm. From 2006-2008, Dr. Kuruvilla was a research fellow at the Broad Institute of Harvard and MIT.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.08 35.38 8.28 0.55